Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emelie Rådestad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Stem Cells International|December 31, 2019
CD8<sup>+</sup> <i>γδ</i> T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune ResponseAhmed Gaballa, Lucas C M Arruda, Emelie Rådestad, et al.
Oncoimmunology|February 5, 2019
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancerEmelie Rådestad, Charlotte Klynning, Arwen Stikvoort, et al.
Oncotarget|March 20, 2016
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytesMelissa M Norström, Emelie Rådestad, Berit Sundberg, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Frontiers in Oncology|October 17, 2018
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF LevelsDeepika Nair, Emelie Rådestad, Prajakta Khalkar, et al.
Oncotarget|September 27, 2017
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissueEmelie Rådestad, Lars Egevad, Carl Jorns, et al.
Frontiers in Immunology|July 5, 2017
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host DiseaseArwen Stikvoort, Yang Chen, Emelie Rådestad, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Stem Cells International|December 31, 2019
CD8<sup>+</sup> <i>γδ</i> T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune ResponseAhmed Gaballa, Lucas C M Arruda, Emelie Rådestad, et al.
Oncoimmunology|February 5, 2019
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancerEmelie Rådestad, Charlotte Klynning, Arwen Stikvoort, et al.
Oncotarget|March 20, 2016
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytesMelissa M Norström, Emelie Rådestad, Berit Sundberg, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Frontiers in Oncology|October 17, 2018
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF LevelsDeepika Nair, Emelie Rådestad, Prajakta Khalkar, et al.
Oncotarget|September 27, 2017
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissueEmelie Rådestad, Lars Egevad, Carl Jorns, et al.
Frontiers in Immunology|July 5, 2017
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host DiseaseArwen Stikvoort, Yang Chen, Emelie Rådestad, et al.
Pageof 1